Mycobacterium is a genus of over 190 species in the phylum Actinomycetota, assigned its own family, Mycobacteriaceae. This genus includes known to cause serious diseases in mammals, including tuberculosis ( M. tuberculosis) and leprosy ( M. leprae) in humans. The Greek language prefix myco- means 'fungus', alluding to this genus' mold-like colony surfaces.
Mycobacterial species are generally aerobic, non-motile, and capable of growing with minimal nutrition. The genus is divided based on each species' pigment production and growth rate.
Microbiology
Morphology
Mycobacteria are
aerobic organism with 0.2-0.6 μm wide and 1.0-10 μm long rod shapes. They are generally non-motile, except for the species
Mycobacterium marinum, which has been shown to be motile within
.
Mycobacteria possess capsules and most do not form
endospores.
M. marinum and perhaps
M. bovis have been shown to
spore;
however, this has been contested by further research.
The distinguishing characteristic of all
Mycobacterium species is a thick,
hydrophobic, and
mycolic acid-rich cell wall made of
peptidoglycan and
arabinogalactan, with these unique components offering targets for new tuberculosis drugs.
Physiology
Many
Mycobacterium species readily grow with minimal nutrients, using
ammonia and/or
as nitrogen sources and
glycerol as a carbon source in the presence of mineral salts. Temperatures for optimal growth vary between species and media conditions, ranging from 25 to 45 °C.
Most Mycobacterium species, including most clinically relevant species, can be cultured in blood agar.
Ecology
Whereas
Mycobacterium tuberculosis and
M. leprae are pathogenic, most mycobacteria do not cause disease unless they enter skin lesions of those with pulmonary and/or immune dysfunction, despite being widespread across aquatic and terrestrial environments. Through
biofilm formation, cell wall resistance to
chlorine, and association with
, mycobacteria can survive a variety of environmental stressors. The agar media used for most
water testing does not support the growth of mycobacteria, allowing it to go undetected in municipal and hospital systems.
Genomics
Hundreds of
Mycobacterium genomes have been completely sequenced.
The genome sizes of mycobacteria range from relatively small ones (e.g. in M. leprae) to quite large ones, such as that as M. vulneris, encoding 6,653 proteins, larger than the ~6000 proteins of Eukaryote yeast.
| +Protein-Coding Genomic Information
!Organism
!Number of Protein Coding Genes |
| M. intracellulare | 5,289 |
| M. colombiense | 5,084 |
| M. leprae | 1,603 |
| M. tuberculosis | 3,995 |
| M. smegmatis | 6,602 |
| M. chelonae | 4,948 |
Pathogenicity
Mycobacterium tuberculosis complex
Mycobacterium tuberculosis can remain latent in human hosts for decades after an initial infection, allowing it to continue infecting others. It has been estimated that a third of the world population has latent tuberculosis (TB).
has many
, which can be divided across lipid and fatty acid metabolism, cell envelope proteins,
macrophage inhibitors,
kinase proteins,
, metal-transporter proteins, and gene expression regulators.
Several lineages such as
M. t. var.
bovis (bovine TB) were considered separate species in the
M, tuberculosis complex until they were finally merged into the main species in 2018.
Leprosy
The development of
leprosy is caused by infection with either
Mycobacterium leprae or
Mycobacterium lepromatosis, two closely related bacteria. Roughly 200,000 new cases of infection are reported each year, and 80% of new cases are reported in Brazil, India, and Indonesia.
infection localizes within the skin macrophages and Schwann cells found in peripheral nerve tissue.
Nontuberculosis Mycobacteria
Nontuberculosis
Mycobacteria (NTM), which exclude
M. tuberculosis, M. leprae, and
M. lepromatosis, can infect mammalian hosts. These bacteria are referred to as "atypical mycobacteria." Although person-to-person transmission is rare, transmission of
M. abscessus has been observed between patients with
cystic fibrosis.
The four primary diseases observed in humans are chronic pulmonary disease, disseminated disease in immunocompromised patients, skin and soft tissue infections, and superficial lymphadenitis. 80-90% of recorded NTM infections manifest as pulmonary diseases.
M. abscessus is the most virulent rapidly-growing mycobacterium (RGM), as well as the leading cause of RGM based pulmonary infections. Although it has been traditionally viewed as an opportunistic pathogen like other NTMs, analysis of various virulence factors (VFs) have shifted this view to that of a true pathogen. This is due to the presence of known mycobacterial VFs and other non-mycobacterial VFs found in other prokaryotic pathogens.
Virulence factors
Mycobacteria have cell walls with
peptidoglycan,
arabinogalactan, and
mycolic acid; a waxy outer mycomembrane of mycolic acid; and an outermost capsule of
and secreted proteins for virulence. It constantly remodels these layers to survive in stressful environments and avoid host immune defenses. This cell wall structure results in colony surfaces resembling fungi, leading to the genus' use of the Greek prefix
myco-.
This unique structure makes
ineffective, instead requiring a multi-drug antibiotic treatment of
isoniazid to inhibit mycolic acid synthesis,
rifampicin to interfere with transcription,
ethambutol to hinder arabinogalactan synthesis, and
pyrazinamide to impede
coenzyme A synthesis.
| + Mycobacterial Infection Information
!Organism
!Common Symptoms of Infection
!Known Treatments
! Reported Cases (Region, Year) |
| M. tuberculosis | Fatigue, weight loss, fever, hemoptysis, chest pain. | isoniazid INH, rifampin, pyrazinamide, ethambutol. | 1.6 Million (Global, 2021) |
| M. leprae
M. lepromatosis | Skin discoloration, nodule development, dry skin, loss of eyebrows and/or eyelashes, numbness, nosebleeds, paralysis, blindness, nerve pain. | dapson, rifampicin, clofazimine. | 133,802 (Global, 2021) |
| M. avium complex | Tender skin, development of boils or pus-filled vesicles, fevers, chills, muscle aches. | clarithromycin, azithromycin, amikacin, cefoxitin, imipenem. | 3000 (US, Annual estimated) |
| M. abscessus complex | Coughing, hemoptysis, fever, cavitary lesions. | clarithromycin, amikacin, cefoxitin, imipenem. | Unknown |
History
Mycobacteria have historically been categorized through phenotypic testing, such as the Runyon classification of analyzing growth rate and production of yellow/orange
carotenoid pigments. Group I contains
photochromogens (pigment production induced by light), Group II comprises
scotochromogens (constitutive pigment production), and the
non-chromogens of Groups III and IV have a pale yellow/tan pigment, regardless of light exposure. Group IV species are "rapidly-growing" mycobacteria compared to the "slowly-growing" Group III species because samples grow into visible colonies in less than seven days.
Because the International Code of Nomenclature of Prokaryotes (ICNP) currently recognizes 195 Mycobacterium species, classification and identification systems now rely on DNA sequencing and computational phylogenetics. The major disease-causing groups are the M. tuberculosis complex (tuberculosis), M. avium complex (mycobacterium avium-intracellulare infection), M. leprae and M. lepromatosis (leprosy), and M. abscessus (chronic lung infection).
Microbiologist Enrico Tortoli has constructed a phylogenetic tree of the genus' key species based on the earlier genetic sequencing of Rogall, et al. (1990), alongside new phylogentic trees based on Tortoli's 2017 sequencing of 148 Mycobacterium species:
File:Phylogentic Tree of Slowly-Growing Mycobacterium Tortoli 2017.png|Phylogenetic tree of slowly-growing members of the Mycobacterium genus
File:Phylogentic Tree of Rapidly-Growing Mycobacterium Tortoli 2017.png|Phylogenetic tree of rapidly-growing members of the Mycobacterium genus, alongside the M. terrae complex.
Proposed division of the genus
Gupta
et al. have proposed dividing
Mycobacterium into five genera, based on an analysis of 150 species in this genus. Due to controversy over complicating clinical diagnoses and treatment, all of the renamed species have retained their original identity in the
Mycobacterium genus as a valid taxonomic synonym:
-
Mycobacterium based on the Slowly-Growing Tuberculosis-Simiae clade
-
Mycobacteroides based on the Rapidly-Growing Abscessus-Chelonae clade
-
Mycolicibacillus based on the Slowly-Growing Triviale clade
-
Mycolicibacter based on the Slowly-Growing Terrae clade
-
Mycolicibacterium based on the Rapidly-Growing Fortuitum-Vaccae clade
Diagnosis
The two most common methods for visualizing these acid-fast bacilli as bright red against a blue background are the Ziehl-Neelsen stain and
Kinyoun stain. Fite's stain is used to color
M. leprae cells as pink against a blue background. Rapid Modified Auramine O Fluorescent staining has specific binding to slowly-growing mycobacteria for yellow staining against a dark background. Newer methods include Gomori-Methenamine Silver staining and Perioidic Acid Schiff staining to color
Mycobacterium avium complex (MAC) cells black and pink, respectively.
While some mycobacteria can take up to eight weeks to grow visible colonies from a cultured sample, most clinically relevant species will grow within the first four weeks, allowing physicians to consider alternative causes if negative readings continue past the first month.[From left to right in image of slant tubes of Löwenstein-Jensen medium:]
- Negative control
- M. tuberculosis: Dry-appearing colonies
- Mycobacterium avium complex: Wet-appearing colonies
- M. gordonae: Yellowish colonies
File:Mycobacteria Growth Indicator Tube (MGIT) samples in ultraviolet light.jpg|MGIT samples emitting fluorescence in ultraviolet light
Mycobacteriophages
Mycobacteria can be infected by mycobacteriophages, a class of viruses with high specificity for their targets. By hijacking the cellular machinery of mycobacteria to produce additional phages, such viruses can be used in
phage therapy for eukaryotic hosts, as they would die alongside the mycobacteria. Since only some mycobacteriophages are capable of penetrating the
M. tuberculosis membrane, the viral DNA may be delivered through artificial
because bacteria uptake, transcribe, and translate foreign DNA into proteins.
Mycosides
Mycosides are
isolated from
Mycobacterium species with Mycoside A found in photochromogenic strains, Mycoside B in bovine strains, and Mycoside C in avian strains.
Different forms of Mycoside C have varying success as a receptor to inactivate mycobacteriophages.
Replacement of the gene encoding mycocerosic acid synthase in
M. bovis prevents formation of mycosides.
Notes
External links
